These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11325452)

  • 1. Local control of T3N0 glottic carcinoma by 60 Gy given over five weeks in 2.4 Gy daily fractions. One more point on the biological effective dose (BED) curve.
    Jackson SM; Hay JH; Flores AD
    Radiother Oncol; 2001 May; 59(2):219-20. PubMed ID: 11325452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
    Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
    Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical radiobiology of glottic T1 squamous cell carcinoma.
    Skladowski K; Tarnawski R; Maciejewski B; Wygoda A; Slosarek K
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):101-6. PubMed ID: 9989520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
    Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
    Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
    Garden AS; Forster K; Wong PF; Morrison WH; Schechter NR; Ang KK
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):322-8. PubMed ID: 12527044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated radiotherapy for T1, 2 glottic carcinoma: analysis of results with KI-67 index.
    Sakata K; Oouchi A; Nagakura H; Akiba H; Tamakawa M; Koito K; Hareyama M; Asakura K; Satoh M; Ohtani S
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):81-8. PubMed ID: 10758308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience.
    Gowda RV; Henk JM; Mais KL; Sykes AJ; Swindell R; Slevin NJ
    Radiother Oncol; 2003 Aug; 68(2):105-11. PubMed ID: 12972304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated radiotherapy for T1 to T2 glottic cancer.
    Motegi A; Kawashima M; Arahira S; Zenda S; Toshima M; Onozawa M; Hayashi R; Akimoto T
    Head Neck; 2015 Apr; 37(4):579-84. PubMed ID: 24677592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
    Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
    Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control.
    Nishimura Y; Nagata Y; Okajima K; Mitsumori M; Hiraoka M; Masunaga S; Ono K; Shoji K; Kojima H
    Radiother Oncol; 1996 Sep; 40(3):225-32. PubMed ID: 8940749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study.
    Moon SH; Cho KH; Chung EJ; Lee CG; Lee KC; Chai GY; Kang KM; Lee JY; Chung WK; Park WY; Kim JH
    Radiother Oncol; 2014 Jan; 110(1):98-103. PubMed ID: 24161568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.
    Laccourreye O; Brasnu D; Bassot V; Ménard M; Khayat D; Laccourreye H
    J Clin Oncol; 1996 Aug; 14(8):2331-6. PubMed ID: 8708725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation treatment of glottic squamous cell carcinoma, stage I and II: analysis of factors affecting prognosis.
    Franchin G; Minatel E; Gobitti C; Talamini R; Sartor G; Caruso G; Grando G; Politi D; Gigante M; Toffoli G; Trovò MG; Barzan L
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):541-8. PubMed ID: 9486602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation therapy of glottic carcinoma: Peter MacCallum Cancer Institute experience.
    Guiney M; Smith J; Hughes P; Narayan K
    Aust N Z J Surg; 1992 Aug; 62(8):622-7. PubMed ID: 1642583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation therapy in early carcinoma of the glottic larynx T1N0M0.
    Medini E; Medini A; Gapany M; Levitt SH
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1211-3. PubMed ID: 8985045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of overall treatment time of radiation therapy on local control of T1-stage squamous cell carcinoma of the glottis.
    Hayakawa K; Mitsuhashi N; Akimoto T; Maebayashi K; Ishikawa H; Hayakawa K; Sakurai H; Takahashi T; Kamei T; Niibe H
    Laryngoscope; 1996 Dec; 106(12 Pt 1):1545-7. PubMed ID: 8948620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a multi-institutional, randomized, non-inferiority, phase III trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group Study (JCOG0701).
    Kodaira T; Kagami Y; Shibata T; Shikama N; Nishimura Y; Ishikura S; Nakamura K; Saito Y; Matsumoto Y; Teshima T; Ito Y; Akimoto T; Nakata K; Toshiyasu T; Nakagawa K; Nagata Y; Nishimura T; Uno T; Kataoka M; Yorozu A; Hiraoka M;
    Ann Oncol; 2018 Apr; 29(4):992-997. PubMed ID: 29401241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone.
    Furusaka T; Matuda H; Saito T; Katsura Y; Ikeda M
    Acta Otolaryngol; 2012 May; 132(5):546-51. PubMed ID: 22264025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
    Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
    Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.